Cargando…

Assessment and Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer: A Comparison of Imaging Modalities and Future Perspectives

SIMPLE SUMMARY: Nowadays patients affected by locally advanced breast cancer and particular subtypes of early breast cancer may benefit from neoadjuvant chemotherapy (NAC) before surgery with different advantageous, like reduction of tumor size and prognosis improvement. Pathological complete respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Romeo, Valeria, Accardo, Giuseppe, Perillo, Teresa, Basso, Luca, Garbino, Nunzia, Nicolai, Emanuele, Maurea, Simone, Salvatore, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303777/
https://www.ncbi.nlm.nih.gov/pubmed/34298733
http://dx.doi.org/10.3390/cancers13143521
_version_ 1783727170954199040
author Romeo, Valeria
Accardo, Giuseppe
Perillo, Teresa
Basso, Luca
Garbino, Nunzia
Nicolai, Emanuele
Maurea, Simone
Salvatore, Marco
author_facet Romeo, Valeria
Accardo, Giuseppe
Perillo, Teresa
Basso, Luca
Garbino, Nunzia
Nicolai, Emanuele
Maurea, Simone
Salvatore, Marco
author_sort Romeo, Valeria
collection PubMed
description SIMPLE SUMMARY: Nowadays patients affected by locally advanced breast cancer and particular subtypes of early breast cancer may benefit from neoadjuvant chemotherapy (NAC) before surgery with different advantageous, like reduction of tumor size and prognosis improvement. Pathological complete response to NAC is very variable amongst all different histological and immunophenotypic subtypes of breast cancer and its correct assessment by imaging is crucial for treatment planning, as patients could be addressed to conservative or demolitive breast surgery with reconstruction. Advanced imaging techniques, such as MRI and nuclear medicine, recently contributed to the prediction of chemotherapy response in the early phase of NAC, to avoid side effects and psychological implications of the oncological treatment in patients who are supposed to be unresponsive. This review article aims to compare different imaging techniques for both assessment and prediction of response to NAC and explain the new revolutionary contribute offered by Artifical Intelligence in this field. ABSTRACT: Neoadjuvant chemotherapy (NAC) is becoming the standard of care for locally advanced breast cancer, aiming to reduce tumor size before surgery. Unfortunately, less than 30% of patients generally achieve a pathological complete response and approximately 5% of patients show disease progression while receiving NAC. Accurate assessment of the response to NAC is crucial for subsequent surgical planning. Furthermore, early prediction of tumor response could avoid patients being overtreated with useless chemotherapy sections, which are not free from side effects and psychological implications. In this review, we first analyze and compare the accuracy of conventional and advanced imaging techniques as well as discuss the application of artificial intelligence tools in the assessment of tumor response after NAC. Thereafter, the role of advanced imaging techniques, such as MRI, nuclear medicine, and new hybrid PET/MRI imaging in the prediction of the response to NAC is described in the second part of the review. Finally, future perspectives in NAC response prediction, represented by AI applications, are discussed.
format Online
Article
Text
id pubmed-8303777
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83037772021-07-25 Assessment and Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer: A Comparison of Imaging Modalities and Future Perspectives Romeo, Valeria Accardo, Giuseppe Perillo, Teresa Basso, Luca Garbino, Nunzia Nicolai, Emanuele Maurea, Simone Salvatore, Marco Cancers (Basel) Review SIMPLE SUMMARY: Nowadays patients affected by locally advanced breast cancer and particular subtypes of early breast cancer may benefit from neoadjuvant chemotherapy (NAC) before surgery with different advantageous, like reduction of tumor size and prognosis improvement. Pathological complete response to NAC is very variable amongst all different histological and immunophenotypic subtypes of breast cancer and its correct assessment by imaging is crucial for treatment planning, as patients could be addressed to conservative or demolitive breast surgery with reconstruction. Advanced imaging techniques, such as MRI and nuclear medicine, recently contributed to the prediction of chemotherapy response in the early phase of NAC, to avoid side effects and psychological implications of the oncological treatment in patients who are supposed to be unresponsive. This review article aims to compare different imaging techniques for both assessment and prediction of response to NAC and explain the new revolutionary contribute offered by Artifical Intelligence in this field. ABSTRACT: Neoadjuvant chemotherapy (NAC) is becoming the standard of care for locally advanced breast cancer, aiming to reduce tumor size before surgery. Unfortunately, less than 30% of patients generally achieve a pathological complete response and approximately 5% of patients show disease progression while receiving NAC. Accurate assessment of the response to NAC is crucial for subsequent surgical planning. Furthermore, early prediction of tumor response could avoid patients being overtreated with useless chemotherapy sections, which are not free from side effects and psychological implications. In this review, we first analyze and compare the accuracy of conventional and advanced imaging techniques as well as discuss the application of artificial intelligence tools in the assessment of tumor response after NAC. Thereafter, the role of advanced imaging techniques, such as MRI, nuclear medicine, and new hybrid PET/MRI imaging in the prediction of the response to NAC is described in the second part of the review. Finally, future perspectives in NAC response prediction, represented by AI applications, are discussed. MDPI 2021-07-14 /pmc/articles/PMC8303777/ /pubmed/34298733 http://dx.doi.org/10.3390/cancers13143521 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Romeo, Valeria
Accardo, Giuseppe
Perillo, Teresa
Basso, Luca
Garbino, Nunzia
Nicolai, Emanuele
Maurea, Simone
Salvatore, Marco
Assessment and Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer: A Comparison of Imaging Modalities and Future Perspectives
title Assessment and Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer: A Comparison of Imaging Modalities and Future Perspectives
title_full Assessment and Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer: A Comparison of Imaging Modalities and Future Perspectives
title_fullStr Assessment and Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer: A Comparison of Imaging Modalities and Future Perspectives
title_full_unstemmed Assessment and Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer: A Comparison of Imaging Modalities and Future Perspectives
title_short Assessment and Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer: A Comparison of Imaging Modalities and Future Perspectives
title_sort assessment and prediction of response to neoadjuvant chemotherapy in breast cancer: a comparison of imaging modalities and future perspectives
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303777/
https://www.ncbi.nlm.nih.gov/pubmed/34298733
http://dx.doi.org/10.3390/cancers13143521
work_keys_str_mv AT romeovaleria assessmentandpredictionofresponsetoneoadjuvantchemotherapyinbreastcanceracomparisonofimagingmodalitiesandfutureperspectives
AT accardogiuseppe assessmentandpredictionofresponsetoneoadjuvantchemotherapyinbreastcanceracomparisonofimagingmodalitiesandfutureperspectives
AT perilloteresa assessmentandpredictionofresponsetoneoadjuvantchemotherapyinbreastcanceracomparisonofimagingmodalitiesandfutureperspectives
AT bassoluca assessmentandpredictionofresponsetoneoadjuvantchemotherapyinbreastcanceracomparisonofimagingmodalitiesandfutureperspectives
AT garbinonunzia assessmentandpredictionofresponsetoneoadjuvantchemotherapyinbreastcanceracomparisonofimagingmodalitiesandfutureperspectives
AT nicolaiemanuele assessmentandpredictionofresponsetoneoadjuvantchemotherapyinbreastcanceracomparisonofimagingmodalitiesandfutureperspectives
AT maureasimone assessmentandpredictionofresponsetoneoadjuvantchemotherapyinbreastcanceracomparisonofimagingmodalitiesandfutureperspectives
AT salvatoremarco assessmentandpredictionofresponsetoneoadjuvantchemotherapyinbreastcanceracomparisonofimagingmodalitiesandfutureperspectives